I assume fundamentally NEU is in a very good shape. We have a pe of less than 10 now, with only one approved condition while the same can be used in 4 rare conditions. On top we are getting revenue from US market only, while revenue from Canada, eu, japan and rest of world still awaits.
To me this stock looks like derisked stock for a long term holders.
My only concern is why acadia will pay more for the product while they already have selling rights for the product. I mean for all the four conditions product is same.
dyor
- Forums
- ASX - By Stock
- Ann: 2024 results - A$166m comprehensive income for shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.28%
!
$12.54

I assume fundamentally NEU is in a very good shape. We have a pe...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 665 | $12.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.55 | 235 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 665 | 12.500 |
1 | 1537 | 12.470 |
1 | 1537 | 12.450 |
2 | 2037 | 12.420 |
1 | 42 | 12.400 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 899 | 1 |
12.690 | 1537 | 1 |
12.720 | 2537 | 2 |
12.730 | 1010 | 1 |
12.750 | 1537 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |